The Vantage Peptides Referral Program is a private, invitation-friendly program designed for professionals and researchers who routinely interact with peers, colleagues, and institutions that purchase research peptides. If your network includes individuals or organizations who would benefit from access to high-purity, US-manufactured research compounds, we invite you to participate.
How It Works
The program is straightforward. Once approved, you receive a unique referral identifier that may be shared directly with qualified contacts or applied at checkout. When a referred customer completes a purchase, a referral fee is credited to your account. Payouts are processed monthly via Zelle or PayPal.
Referral Tiers
Referral compensation is structured according to the volume of qualified introductions over a rolling 90-day period:
Standard tier — 10% on each qualifying order
Established tier — 15% on each qualifying order, available to participants maintaining consistent monthly referral activity
Partner tier — Up to 20% on each qualifying order, reserved for participants with sustained high-volume referral activity and demonstrated alignment with Vantage Peptides' standards
Tier eligibility is reviewed quarterly. New participants begin at the Standard tier and may advance based on performance.

We work with a limited number of referral partners and prioritize quality of fit over quantity. Suitable participants typically include:
We welcome partners who reach audiences interested in health optimization, longevity, and performance research — whether through a podcast, newsletter, professional network, or educational platform — provided their content presents peptide science with the rigor and research-oriented framing our products require.
Compounding pharmacists and procurement specialists
Practitioners operating within the research and academic space Industry consultants with established relationships in the peptide research community
Program Standards
All participants are expected to represent Vantage Peptides accurately and in accordance with our Research Use Only Policy. Referral activity must comply with applicable laws, platform policies, and advertising regulations. Participants may not make therapeutic claims, suggest human consumption, or imply medical efficacy of any product. Misrepresentation, off-label promotion, or any conduct inconsistent with our policies will result in immediate removal from the program and forfeiture of pending commissions.
Application
Participation is by application only. To request consideration, please contact us at [email protected] with a brief description of your professional background and the audience or network you would be introducing to Vantage Peptides. Applications are typically reviewed within five business days.
Program Terms
Referral fees apply to first-time and recurring qualified orders placed by referred customers. Self-referrals, fraudulent transactions, and orders subsequently refunded are excluded. Vantage Peptides reserves the right to modify program terms, adjust tier thresholds, or discontinue the program at any time. Full program terms are provided upon acceptance.
Vantage Peptides products are sold for research use only. The Referral Program is intended exclusively for the introduction of qualified research customers and is not a solicitation for the promotion of products to end consumers for personal use.
© Vantage Peptides 2026. All rights reserved.
All products offered on this website are provided exclusively for laboratory research and development purposes. They are not intended for human consumption under any circumstances. Statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Our products and related information are not intended to diagnose, treat, cure, or prevent any disease.
Vantage Peptides is a research chemical supplier. We are not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B of the same Act.